LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.888
EU - Europa 13.672
AS - Asia 6.655
SA - Sud America 940
AF - Africa 90
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.700
IT - Italia 6.658
GB - Regno Unito 3.218
SG - Singapore 2.534
CN - Cina 2.047
HK - Hong Kong 863
SE - Svezia 835
BR - Brasile 762
DE - Germania 707
RU - Federazione Russa 360
UA - Ucraina 355
NL - Olanda 304
VN - Vietnam 303
FI - Finlandia 301
FR - Francia 285
TR - Turchia 253
BG - Bulgaria 149
KR - Corea 147
IN - India 115
ID - Indonesia 113
CA - Canada 90
AR - Argentina 77
AL - Albania 76
PL - Polonia 66
MX - Messico 65
ES - Italia 55
BE - Belgio 48
JP - Giappone 47
BD - Bangladesh 43
ZA - Sudafrica 43
IE - Irlanda 42
LT - Lituania 40
RO - Romania 40
AE - Emirati Arabi Uniti 28
IQ - Iraq 27
MY - Malesia 24
EC - Ecuador 23
CH - Svizzera 22
CZ - Repubblica Ceca 20
PK - Pakistan 19
CL - Cile 18
LV - Lettonia 16
CO - Colombia 15
UZ - Uzbekistan 14
PY - Paraguay 13
AT - Austria 11
IL - Israele 11
IR - Iran 11
MA - Marocco 11
PT - Portogallo 11
PE - Perù 10
DK - Danimarca 9
VE - Venezuela 9
GR - Grecia 8
AU - Australia 7
KE - Kenya 7
UY - Uruguay 7
BO - Bolivia 6
KG - Kirghizistan 6
NO - Norvegia 6
PH - Filippine 6
SA - Arabia Saudita 6
BZ - Belize 5
CR - Costa Rica 5
EG - Egitto 5
MD - Moldavia 5
NP - Nepal 5
SI - Slovenia 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
GT - Guatemala 4
KZ - Kazakistan 4
PA - Panama 4
TH - Thailandia 4
EU - Europa 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
EE - Estonia 2
HN - Honduras 2
MK - Macedonia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
RE - Reunion 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 41.241
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Santa Clara 1.677
Fairfield 1.665
Singapore 1.535
Ashburn 1.470
Woodbridge 1.129
Chicago 990
Chandler 940
Hong Kong 858
Houston 826
Jacksonville 680
Seattle 664
Wilmington 649
Los Angeles 621
Hefei 601
Cambridge 591
Rome 579
Dearborn 574
Ann Arbor 532
Nyköping 485
Salt Lake City 439
Milan 403
London 366
Beijing 346
Modena 334
New York 233
Elk Grove Village 215
Tampa 209
San Diego 175
Naples 163
Princeton 157
Helsinki 153
Shanghai 146
Izmir 145
Seoul 139
Bologna 138
Sofia 138
Dallas 137
Eugene 130
Sterling 125
Council Bluffs 123
Lancaster 113
Bari 109
Frankfurt am Main 109
The Dalles 109
Turin 109
Moscow 100
Buffalo 93
Jakarta 88
São Paulo 87
Ho Chi Minh City 86
Palermo 86
Florence 84
Munich 83
Hanoi 79
Bremen 77
Cagliari 69
Parma 65
Verona 64
Columbus 63
Detroit 63
Tirana 63
Miami 62
Des Moines 60
Dulles 60
Phoenix 57
Reggio Emilia 57
Perugia 54
Boardman 51
Redwood City 51
Catania 48
Fremont 47
Warsaw 46
San Jose 43
Tokyo 42
Padova 41
Atlanta 39
Denver 39
Dublin 39
Brussels 36
Genoa 35
Trieste 34
Brooklyn 33
Falls Church 33
Pescara 33
Stockholm 33
Guangzhou 32
Kansas City 32
Pittsburgh 31
Brescia 30
Nanjing 29
Toronto 29
Napoli 28
Rio de Janeiro 28
Turku 28
Jersey City 26
Kunming 25
Ottawa 25
Kent 23
Dong Ket 22
Totale 27.236
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 6.167
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 462
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 409
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 404
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 401
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 398
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 398
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 390
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 380
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 377
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 370
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 370
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 369
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 366
K-ras and p53 mutations in human colorectal aberrant crypt foci 364
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 356
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 354
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 349
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 345
Microsatellite instability in multiple colorectal tumors 345
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 342
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 340
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 338
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 337
Repurposing of drugs targeting yap-tead functions 333
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 333
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 331
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 329
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 327
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 324
Prognostic significance of K-ras mutations in colorectal carcinoma. 324
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 323
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 318
Aberrant crypt foci in patients with colorectal cancer 317
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 317
Aetiology of colorectal cancer and relevance of monogenic inheritance. 315
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 313
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 312
Histology of aberrant crypt foci in the human colon 307
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 307
Expression of p53 protein in prostate cancers of different histologic types. 307
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 306
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 302
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 301
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 299
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 292
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 292
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 292
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 286
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 284
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 283
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 282
Paneth and argyrophil cells in prostatic carcinoma. 281
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 279
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 276
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 269
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 267
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 266
Desmoplastic melanoma: a challenge for the oncologist 265
Primary mucinous (so-called colloid) carcinomas of the lung - A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression 263
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 263
Microsatellite instability and colorectal cancer prognosis. 257
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 256
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 255
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 255
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 253
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 246
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 246
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 245
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 243
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 242
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 240
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 239
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 234
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 231
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 230
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 227
Colorectal carcinoma in different age groups: A population based investigation 226
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 224
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 224
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 221
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 220
Biological characterization of mucinous carcinoma of the colon and rectum 219
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 219
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 218
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 218
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 216
Myxoid metastases of melanoma: report of three cases and review of the literature 214
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 208
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 205
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 201
Survival for colon and rectal cancer in a population-based cancer registry 199
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 198
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours 195
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 195
Cardiac arrhythmias after intramyocardial administration of mesenchymal bone marrow stem cells in acute myocardial infarction 191
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 191
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 190
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 189
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 189
Totale 34.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.752
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.246 0 0 0 0 0 319 324 474 231 432 243 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/20258.195 314 144 308 676 1.443 1.094 640 541 969 413 725 928
2025/202610.102 813 550 917 2.524 4.435 863 0 0 0 0 0 0
Totale 41.500